Clear, practical articles about medicines, active ingredients, treatment areas, and informed next steps.
521 articles found
Tenofovir Alafenamide (TAF) is an advanced target-directed antiviral therapy categorized as a nucleotide reverse transcriptase inhibitor (NRTI). It belongs to a modern class of prodrug precision antiviral agents used primarily in the management of chronic viral infections. Unlike older systemic NRTI…
Read articleTrelagliptin (commonly formulated as Trelagliptin Succinate) is an orally active, highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor used to improve blood sugar (glucose) control in adult patients with Type 2 Diabetes Mellitus (T2DM). It is a targeted antidiabetic medication designed to enhan…
Read articleSofosbuvir + Velpatasvir is an orally active, pan-genotypic direct-acting antiviral (DAA) fixed-dose combination used to treat chronic Hepatitis C virus (HCV) infection. It combines two targeted antivirals—sofosbuvir and velpatasvir—designed to directly inhibit essential viral proteins required for…
Read articleRegorafenib is a targeted cancer therapy categorized as an oral multikinase inhibitor (a type of tyrosine kinase inhibitor, or TKI). It belongs to a modern class of precision medicines used primarily in the management of specific types of advanced or refractory solid tumors. Unlike traditional cytot…
Read articleAfatinib is a targeted cancer therapy categorized as an irreversible tyrosine kinase inhibitor (TKI). It belongs to a modern class of precision medicines used primarily in the management of specific types of non-small cell lung cancer (NSCLC). Unlike traditional treatments, Afatinib works at the mol…
Read articleEltrombopag is an orally active thrombopoietin receptor agonist (TPO-RA) used to increase platelet counts in patients with low platelet levels (thrombocytopenia). It is a targeted precision medication designed to stimulate the bone marrow to produce more platelets, helping lower the risk of excessiv…
Read articleCrizotinib is a targeted therapy categorized as a selective tyrosine kinase inhibitor (TKI). It is a first-in-class precision medicine used for treating specific types of non-small cell lung cancer (NSCLC) and certain rare soft-tissue tumors. By targeting and blocking the specific abnormal proteins…
Read articleIbrutinib is a targeted therapy categorized as a selective BTK (Bruton's tyrosine kinase) inhibitor. It is a first-in-class precision medicine used for treating specific types of B-cell malignancies (blood cancers) and certain immune-related conditions. By targeting the specific biological pathways…
Read articlePalbociclib is a targeted therapy categorized as a selective CDK4/6 (cyclin-dependent kinase 4 and 6) inhibitor. It is used for treating specific types of advanced or metastatic breast cancers. As a precision medicine, it disrupts the division of cancer cells, slowing down tumor progression and impr…
Read articleOsimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used for the treatment of specific types of EGFR mutation-positive non-small cell lung cancer (NSCLC). It is a precision medicine designed to target cancer cells carrying specific EGFR mutations…
Read article
